Rolled into one? Weeding out evidence on cognitive impact of marijuana from that of THC

Cannabis (also known as Marijuana), an umbrella term encompassing natural and bred plant varieties, contains over 100 distinct cannabinoids and other bioactive molecules in varying ratios, yet all are commonly conflated with the prime euphorigenic cannabinoid, Δ-9 etrahydrocannabinol (THC).¹ A lack of appreciation for this distinction, along with media sensationalism, have created misinformation about the biological actions of specific cannabinoids, for instance, that regarding the cognitive impact of THC versus cannabis in general.

 

This supplement to Neurology Reviews summarizes summarize findings from English-only, peer-reviewed original articles and meta-analyses of specified cannabinoids’ effect on cognition in preclinical and clinical literature, where known, to guide practitioners with proper evidence and highlighting gaps in knowledge for future research.

Click here to read the supplement. 

 

Authors

Francesca Filbey, PhD
Bert Moore Chair and Professor
of Cognition and Neuroscience
The University of Texas at Dallas

Chris Hauser, PhD
Medical Science Liaison
Greenwich Biosciences, Inc.

Karthik Rajasekaran, PhD
Sr. Medical Science Liaison
Greenwich Biosciences, Inc.

 

1. Mead A. Front Plant Sci. 2019;10:697.

Cannabis (also known as Marijuana), an umbrella term encompassing natural and bred plant varieties, contains over 100 distinct cannabinoids and other bioactive molecules in varying ratios, yet all are commonly conflated with the prime euphorigenic cannabinoid, Δ-9 etrahydrocannabinol (THC).¹ A lack of appreciation for this distinction, along with media sensationalism, have created misinformation about the biological actions of specific cannabinoids, for instance, that regarding the cognitive impact of THC versus cannabis in general.

 

This supplement to Neurology Reviews summarizes summarize findings from English-only, peer-reviewed original articles and meta-analyses of specified cannabinoids’ effect on cognition in preclinical and clinical literature, where known, to guide practitioners with proper evidence and highlighting gaps in knowledge for future research.

Click here to read the supplement. 

 

Authors

Francesca Filbey, PhD
Bert Moore Chair and Professor
of Cognition and Neuroscience
The University of Texas at Dallas

Chris Hauser, PhD
Medical Science Liaison
Greenwich Biosciences, Inc.

Karthik Rajasekaran, PhD
Sr. Medical Science Liaison
Greenwich Biosciences, Inc.

 

1. Mead A. Front Plant Sci. 2019;10:697.

Cannabis (also known as Marijuana), an umbrella term encompassing natural and bred plant varieties, contains over 100 distinct cannabinoids and other bioactive molecules in varying ratios, yet all are commonly conflated with the prime euphorigenic cannabinoid, Δ-9 etrahydrocannabinol (THC).¹ A lack of appreciation for this distinction, along with media sensationalism, have created misinformation about the biological actions of specific cannabinoids, for instance, that regarding the cognitive impact of THC versus cannabis in general.

 

This supplement to Neurology Reviews summarizes summarize findings from English-only, peer-reviewed original articles and meta-analyses of specified cannabinoids’ effect on cognition in preclinical and clinical literature, where known, to guide practitioners with proper evidence and highlighting gaps in knowledge for future research.

Click here to read the supplement. 

 

Authors

Francesca Filbey, PhD
Bert Moore Chair and Professor
of Cognition and Neuroscience
The University of Texas at Dallas

Chris Hauser, PhD
Medical Science Liaison
Greenwich Biosciences, Inc.

Karthik Rajasekaran, PhD
Sr. Medical Science Liaison
Greenwich Biosciences, Inc.

 

1. Mead A. Front Plant Sci. 2019;10:697.